Long COVID. It has left millions struggling with tiring symptoms, from chronic fatigue to severe digestive and musculoskeletal complications. Among them was a professional golfer whose health spiraled downward for nearly three years, despite consulting top specialists and undergoing multiple treatments. His case highlights the potential role of stem cell therapy in cases where conventional approaches fail.
The athlete, a US Open qualifier, initially experienced mild digestive symptoms after his COVID-19 vaccination in 2021. However, after contracting COVID-19 in early 2022, his condition worsened drastically. He became severely underweight, dropping from 205 to 126 pounds, and developed food intolerances that made it difficult to consume even water. In addition, he suffered from chronic shoulder pain and sciatica.
Over 18 months, he tried various treatments, including therapies for Lyme disease, Epstein-Barr virus, and mold exposure. Hyperbaric oxygen therapy provided temporary relief, but his symptoms always returned. By early 2024, with his health in critical decline, stem cell therapy became the last resort. He sought stem cell treatment under the guidance of Dr. Chadwick Prodromos at the Prodromos Stem Cell Institute.
The treatment involved a single infusion of 250 million umbilical cord-derived mesenchymal stem cells at the Prodromos Stem Cell Institute’s licensed facility in Antigua. Within days, he noticed improvements—first in his ability to tolerate water, then in his overall digestion and caloric intake. Over the next few months, he regained weight, and remarkably, his musculoskeletal pain resolved without additional treatment. By the end of 2024, he had fully recovered, surpassing his pre-illness strength and resuming competitive golf training.
This case adds to the growing evidence supporting stem cell therapy for long COVID, particularly in severe cases resistant to standard treatments.
